Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial
Journal of the National Comprehensive Cancer Network · 2025-10 · 23 (10)
DOI: 10.6004/jnccn.2025.7054 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-10. Verfasst von Xin Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Radiation Oncology, Emory School of Medicine, Atlanta, GA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hormonal, Breast Neoplasms, Medication Adherence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Adjuvant endocrine therapy (AET) reduces the risk of breast cancer recurrence, but racial differences in nonadherence persist, potentially reflecting variations in symptom burden. We conducted a post hoc analysis of the THRIVE trial to investigate symptom burden and AET adherence by race among women with early-stage breast cancer. Patients and Methods: We included Black and White women who enrolled in the THRIVE trial, a remote monitoring intervention, from November 2018 to June 2021. Participants completed surveys at baseline and at months 6 and 12, including symptom burden measured using the Functional Assessment of Cancer Therapy-Endocrine Subscale (FACT-ES) instrument. Adherence was defined as the proportion of days covered >80% using an electronically monitored pillbox. Multivariable regression analyses were performed to examine factors associated with adherence, and Kitagawa-Oaxaca-Blinder decomposition was used to quantify the proportion of adherence differences explained by symptom and patient characteristics.
Results
Among 102 (34.7%) Black and 192 (65.3%) White women randomized to 3 study arms evaluating the efficacy of the remote monitoring intervention, 84% completed the 6-month survey, and 87% completed the 12-month survey. Black participants were younger and had lower income and health literacy ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1Department of Radiation Oncology, Emory School of Medicine, Atlanta, GA.
- 2Winship Cancer Institute, Emory University, Atlanta, GA.
- 3Department of Public Health Sciences, University of Virginia Comprehensive Cancer Center and School of Medicine, Charlottesville, VA.
- 4Ovation.io, Cambridge, MA.
- 5Department of Community and Population Health, University of Tennessee Health Science Center, Memphis, TN.
- 6West Cancer Center and the Lee S Schwartzberg Research Institute, Germantown, TN.
Förderung
- NCI NIH HHS
Zitieren
APA
Hu, X., Krukowski, R. A., Stepanski, E., Anderson, J. N., Vidal, G. A., Torres, M. A., Schwartzberg, L. S., & Graetz, I. (2025). Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial. Journal of the National Comprehensive Cancer Network, 23(10). https://doi.org/10.6004/jnccn.2025.7054
Vancouver
Hu X, Krukowski RA, Stepanski E, Anderson JN, Vidal GA, Torres MA, et al. Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial. Journal of the National Comprehensive Cancer Network. 2025;23(10). doi:10.6004/jnccn.2025.7054
BibTeX
@article{Hu2025,
author = {Hu, Xin and Krukowski, Rebecca A and Stepanski, Edward and Anderson, Janeane N and Vidal, Gregory A and Torres, Mylin A and Schwartzberg, Lee S and Graetz, Ilana},
title = {Racial Differences in Symptom Burden and Endocrine Therapy Adherence in Breast Cancer: A Post Hoc Analysis of a Randomized Trial},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
volume = {23},
number = {10},
doi = {10.6004/jnccn.2025.7054}
}
EUVIMED